An editorial on a comparison of care quality metrics between Black and White men with advanced prostate cancer in the IRONMAN registry.

An editorial on a comparison of care quality metrics between Black and White men with advanced prostate cancer in the IRONMAN registry.
复制标题

关于 IRONMAN 登记中患有晚期前列腺癌的黑人和白人男性护理质量指标比较的社论。

DOI:
10.1002/cncr.34886
复制
发表时间:
2023
期刊:
影响因子:
6.2
通讯作者:
Murphy,AdamB
Murphy,AdamB
中科院分区:
医学1区
文献类型:
--
作者:
Murphy,AdamB

文献摘要

相似文献

这篇社论重点介绍了发表在《癌症》杂志上题为《黑人和白人晚期前列腺癌患者使用美国医疗保健系统的经验》的手稿中的主要发现。也就是说,在美国晚期前列腺癌男性登记注册网站招募的黑人男性和白人男性在一项调查中报告了类似的、主要是肯定的医疗质量指标。在非国家癌症研究所指定的中心,白人参与者的医疗保健实际上比黑人参与者的医疗保健更差。这项研究的结果表明,临床试验登记可能是提高医疗质量并消除黑人男性差异的一种方式。这种医疗质量好处是否超出了招募黑人男性的少数铁人招募地点,还是超出了医疗质量的几个衡量标准,仍有待观察。
Plain Language SummaryThis editorial highlights key findings from the manuscript entitled “Experience with the US health care system for Black and White patients with advanced prostate cancer” in theCancerjournal. Namely, the Black men and White men recruited in US sites for the International Registry for Men with Advanced Prostate Cancer (IRONMAN) registry reported similar and mainly affirmative responses for health care quality metrics on a survey.In non–National Cancer Institute–designated centers, the care was actually worse for the White participants than for the Black participants. The study's results suggest that clinical trial enrollment may be a way to improve health care quality and eliminate disparities for Black men.Whether this healthcare quality benefit extends beyond the few IRONMAN recruitment sites where Black men were recruited or beyond a few measures of healthcare quality remains to be seen.